Abstract:Binding kinetics play an important role in cancer diagnosis and therapeutics. However, current methods of quantifying binding kinetics fail to consider the three-dimensional environment that drugs and imaging agents experience in biological tissue. In response, a methodology to assay agent binding and dissociation in 3-D tissue culture was developed using paired-agent molecular imaging principles. To test the methodology, the uptakes of ABY-029 (an IRDye 800CW-labeled epidermal growth factor receptor (EGFR)-targeted antibody mimetic) and IRDye-700DX carboxylate in 3-D spheroids were measured in four different human cancer cell lines throughout staining and rinsing. A compartment model (optimized for the application) was then fit to the kinetic curves of both imaging agents to estimate binding and dissociation rate constants of the EGFR-targeted ABY-029 agent. A statistically significant correlation was observed between apparent association rate constant (k3) and the receptor concentration experimentally and in simulations (r = 0.99, p < 0.05). A statistically significant difference was found between effective k3 (apparent rate constant of ABY-029 binding to EGFR) values for cell lines with varying levels of EGFR expression (p < 0.05), with no significant difference found between cell lines and controls for other fit parameters. Additionally, a similar binding affinity profile compared to a gold standard method was determined by this model. This low-cost methodology to quantify imaging agent or drug binding affinity in clinically relevant 3-D tumor spheroid models can be used to guide timing of imaging in molecular guided surgery and could have implications in drug development.

Kinetic Parameters of Interaction Between Cell Membrane and Drug by Ppkce

Membrane-Mediated Interactions Between Nanoparticles on a Substrate

Label-Free Quantification of Molecular Interaction in Live Red Blood Cells by Tracking Nanometer Scale Membrane Fluctuations.

Estimation of Binding Constants of Receptors and Ligands by Affinity Capillary Electrophoresis.

Drug evaluations using a novel microphysiometer based on cell-based biosensors

Ultra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells.

Measuring Receptor–Ligand Binding Kinetics on Cell Surfaces: From Adhesion Frequency to Thermal Fluctuation Methods

Application of Capillary Electrophoresis to Investigate Biomolecular Interactions and Drug Screening

Novel application of capillary electrophoresis with a liposome coated capillary for prediction of blood-brain barrier permeability

Insights into Intercellular Receptor-Ligand Binding Kinetics in Cell Communication.

Study of Small-Molecule-Membrane Protein Binding Kinetics with Nanodisc and Charge-Sensitive Optical Detection

Site selective electron paramagnetic resonance study of photoexcited chromium doped forsterite

A real-time and in-situ monitoring of the molecular interactions between drug carrier polymers and a phospholipid membrane

Interpreting the function of cell penetrating peptide (RGD) in drug transport to the cell membrane: a computational approach

Application of parallel artificial membrane permeability assay technique and chemometric modeling for blood–brain barrier permeability prediction of protein kinase inhibitors

Recent Advances in the Quantitative Determination of Protein Receptor–Ligand Interaction Kinetics

Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles

A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels.

Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability

Microdialysis sampling method for evaluation of binding kinetics of small molecules to macromolecules.

Observed Drug-Receptor Association Rates Are Governed by Membrane Affinity: The Importance of Establishing “Micro-Pharmacokinetic/Pharmacodynamic Relationships” at the β2-Adrenoceptor